Modern nuclear medicine evaluation of neuroblastoma
- PMID: 20823807
Modern nuclear medicine evaluation of neuroblastoma
Abstract
The neuroblastoma is an embryonic tumor of the peripheral sympathetic nervous system, and is metastatic or otherwise high risk for relapse in nearly 50% of cases, with a long-term survival of <40%. Therefore, exact staging with radiological and nuclear medicine imaging methods is crucial for finding the adequate therapeutic choice. The tumor cells express the norepinephrine transporter, which makes metaiodobenzylguanidine (MIBG), an analogue of norepinephrine, an ideal tumor specific agent for imaging. On the other hand, MIBG imaging has several disadvantages as limited spatial resolution, limited sensitivity in small lesions, need for two or even more acquisition sessions, and a delay between the start of the examination and result. Most of these limitations can be overcome with positron emission tomography (PET) using different radiotracers. Furthermore, MIBG imaging is not sufficient for operative or biopsy planning. With this regard, a combination with morphological imaging methods is indispensable. This article will discuss the therapeutic strategy for primary and follow-up diagnosis in neuroblastoma using different nuclear medicine and radiological imaging methods as well as multimodality imaging.
Similar articles
-
Neuroblastoma: MIBG Imaging and New Tracers.Semin Nucl Med. 2017 Mar;47(2):143-157. doi: 10.1053/j.semnuclmed.2016.10.007. Epub 2016 Nov 3. Semin Nucl Med. 2017. PMID: 28237003 Review.
-
Nuclear medicine and multimodality imaging of pediatric neuroblastoma.Pediatr Radiol. 2013 Apr;43(4):418-27. doi: 10.1007/s00247-012-2512-1. Epub 2012 Nov 14. Pediatr Radiol. 2013. PMID: 23151727 Review.
-
Extending positron emission tomography scan utility to high-risk neuroblastoma: fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients.J Clin Oncol. 2001 Jul 15;19(14):3397-405. doi: 10.1200/JCO.2001.19.14.3397. J Clin Oncol. 2001. PMID: 11454888
-
Nuclear medicine procedures and neuroblastoma in childhood. Their value in the diagnosis, staging and assessment of response to therapy.Q J Nucl Med. 2003 Mar;47(1):31-40. Q J Nucl Med. 2003. PMID: 12714952 Review.
-
Radioiodinated meta-iodobenzylguanidine in the diagnosis of childhood neuroblastoma.Q J Nucl Med. 1995 Dec;39(4 Suppl 1):21-4. Q J Nucl Med. 1995. PMID: 9002744
Cited by
-
PET/CT in paediatric oncology: clinical usefulness and dosimetric concerns.Eur J Nucl Med Mol Imaging. 2011 Jan;38(1):179-84. doi: 10.1007/s00259-010-1661-4. Eur J Nucl Med Mol Imaging. 2011. PMID: 21052659 Review. No abstract available.
-
A clinical update and radiologic review of pediatric orbital and ocular tumors.J Oncol. 2013;2013:975908. doi: 10.1155/2013/975908. Epub 2013 Mar 12. J Oncol. 2013. PMID: 23577029 Free PMC article.
-
¹²³I-MIBG scintigraphy/SPECT versus ¹⁸F-FDG PET in paediatric neuroblastoma.Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1648-58. doi: 10.1007/s00259-011-1843-8. Epub 2011 May 27. Eur J Nucl Med Mol Imaging. 2011. PMID: 21617976
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical